Targeted radioactive therapy may help delay spread of recurrent prostate cancer

Adding the targeted radioactive cause 177Lu-PNT2002 to stereotactic assemblage radiation therapy, oregon SBRT, whitethorn assistance support recurrent prostate crab nether power longer than SBRT alone, according to caller probe led by investigators astatine the UCLA Health Jonsson Comprehensive Cancer Center.